A. Michael Lincoff

A. Michael Lincoff, MD, is the Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research). He also oversees clinical research activities throughout the Cleveland Clinic as Director of the Center for Clinical Research and Vice Chairman for Clinical Research of the Lerner Research Institute. He is a Vice Chairman of the Department of Cardiovascular Medicine and an interventional cardiologist in the Heart and Vascular Institute. Dr. Lincoff’s clinical research activities focus on development of therapies to reduce acute and long-term complications of percutaneous coronary revascularization procedures, to optimize therapy for acute coronary ischemic syndromes, or reduce progression or complications of atherosclerosis. He has served as principal investigator or steering committee member of over 15 pivotal trials in ischemic heart disease, enrolling in aggregate over 50,000 patients, studying new antiplatelet or antithrombotic agents in the settings of coronary intervention, heart attack, or unstable angina. Dr. Lincoff is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds the Charles and Charlotte Fowler Endowed Chair for Cardiovascular Research at the Cleveland Clinic. Dr. Lincoff has authored or coauthored over 200 peer-reviewed articles. He has also written over 80 book chapters and reviews and presented more than 300 lectures at various medical meetings and courses throughout the world. Dr. Lincoff is currently a member of the Cardiovascular and Renal Drugs Advisory Committee of the United States Food and Drug Administration.